[Atrio-biventricular electrostimulation in the treatment of congestive heart failure. Case report]

M L Bencić1, D Milicić, D Kosi

  • 1Klinicki bolnicki centar, Zagreb.

Lijecnicki Vjesnik
|October 21, 2000
PubMed

Insights

Multisite, biventricular cardiac pacing shows promise for improving heart failure symptoms and quality of life in patients with dilated cardiomyopathy. This advanced pacing technique offers functional benefits, aligning with current research trends.

Area of Science:

  • Cardiology
  • Medical Devices

Background:

  • Indications for permanent cardiac pacing have expanded, including dilated cardiomyopathy and hypertrophic obstructive cardiomyopathy.
  • Dual-chamber pacing has shown benefits in heart failure with dilated cardiomyopathy.
  • Multisite, biventricular pacing has emerged as a potentially more effective approach.

Observation:

  • A patient with dilated cardiomyopathy (NYHA class IV), awaiting heart transplantation, received a multisite pacemaker (InSync).
  • The patient met established criteria for multisite pacemaker implantation.

Findings:

  • The patient experienced functional improvement during an eleven-month follow-up.
  • Observed enhancements included a better 6-minute walking test performance.
  • Quality of life also improved significantly.

Implications:

  • Multisite, biventricular pacing may offer significant benefits for select heart failure patients.
  • This approach aligns with and supports current literature on advanced cardiac pacing.
  • Further research into multisite pacing for advanced heart failure is warranted.

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...